Medtronic conducted a post market clinical follow-up (pmcf) survey to seek out potential new risks and assess performance of the sentrant device.The exact size of the device is unknown.Survey results from an interventional cardiologist in practice 14 years, who has used the device 60 times in total over the last 27 months and 30 times in the last 12 months.During use of the sentrant, the following complications was encountered; vascular trauma - dissection with pseudoaneurysm formation.The physician found the events to be somewhat concerning or not at all concerning and not related to the device.No further information has or will be provided.
|